Mark Suzman, CEO of the Gates Foundation, sees the current global funding challenges as an opportunity for India to lead, particularly in h...

Warren Buffett, chairman of Berkshire Hathaway, has revised his will to redirect his considerable fortune away from the Bill & Melinda Gate...

Melinda Gates (Google Trends): On Monday, Melinda French Gates declared her intention to resign as co-chair of the Bill & Melinda Gates Fou...

According to a statement by the British High Commission, the initiative aimed at fostering "safe and responsible" AI programming, will seek...

The annual Goalkeepers Report published by the Gates foundation reveals that global public health challenges have worsened due to Covid-rel...

Suzman's comments came on a day the foundation released its sixth annual "Goalkeepers" report that noted that nearly every indicator of the...

Bill & Melinda Gates Foundation CEO Mark Suzman also cited India's leadership in manufacturing of vaccines including by the SII and Bharat ...

Only better surveillance can track multiple variants. Covid-19 has been a global challenge and it needs a global response. So, whatever too...

Decisions still require both Gates and French Gates to support them, in essence handing them each veto power.

"India’s response has been very strong. This pandemic has posed a unique challenge in every country because the world hasn’t faced somethin...

Wednesday's announcement means the global charitable group will now have six people to guide its work and its USD 50 billion endowment. How...

The health crisis cast a shadow over many measures of well-being.

The foundation plans to add additional trustees outside their close circle.

The divorce put Buffett in an awkward position as tie-breaker for the two exes.

The foundation has become one of the most powerful and influential forces in global public health.

In an interview to, Suzman noted that India is doing everything it can right now with the resources at hand to fight the COVID-19 pandemic.

The foundation also plans to commit up to $60 mn to accelerate the discovery, development and testing of vaccines.